To some, the line dividing non-drug form drug products is vague and seemingly unreadable. Most companies go out of their way not to cross the line, in the hopes of not having to deal with the regulatory issues that come with marketing drug products. Yet, more and more often, as new claims come onto the market, the exact point at which your product becomes a drug and not a cosmetic comes into the picture as a critical consideration in product development and marketing.
Establishing the Dividing Line: Is Your Product a Drug?
November 4, 2011
Fill out my online form.
Most Popular in Claims/Labeling
- 1The INCI Name Game: A Commentary
- 2Into the Weeds: Walking the Regulatory Line of CBD in Cosmetics
- 3Diatomaceous Earth and Comfrey Root Catch the FDA's Eye
- 4FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 5The Least Credible Claims in Skin Care
- 6No Eco-scuses: Packaging Can Conform with Natural Tenets
- 7Making Hair (Claims) Do What You Want
- 8The EU Fragrance Allergens
- 9Beginner's Guide to Natural/Organic
- 10VIDEO: Seki's Schroeder on toxicological profiling, animal testing ban
- Beginner's Guide to Natural/Organic
2/5/2019, John I. Yablonski, Bio-Control Consultants, LLC, Park City, UT, and David R. Winne, Claims Support Group, LLC, Cold Spring, NY
- SkinTrust Society Sets a New Global Standard
8/24/2018, Eden Stuart
- Back to Basics, Part II: Ensuring Product Safety
4/29/2019, Pascal Yvon, BioSciences Expansion, LLC, Newtown, PA U.S.
- The INCI Name Game: A Commentary
7/12/2019, Rachel Grabenhofer
- Claire's, Beauty Plus Global Recall Certain Cosmetics After Asbestos Testing
6/7/2019, Brooke Schleehauf